564 related articles for article (PubMed ID: 28404961)
21. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients.
Gu X; Sun S; Gao XS; Xiong W; Qin S; Qi X; Ma M; Li X; Zhou D; Wang W; Yu H
Sci Rep; 2016 Mar; 6():23893. PubMed ID: 27025911
[TBL] [Abstract][Full Text] [Related]
22. Platelet-to-lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta-analysis.
Peng HX; Lin K; He BS; Pan YQ; Ying HQ; Hu XX; Xu T; Wang SK
FEBS Open Bio; 2016 Jul; 6(7):742-50. PubMed ID: 27398314
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of neutrophil-lymphocyteratio/platelet-lymphocyteratioin lung cancers: a meta-analysis.
Yang HB; Xing M; Ma LN; Feng LX; Yu Z
Oncotarget; 2016 Nov; 7(47):76769-76778. PubMed ID: 27732958
[TBL] [Abstract][Full Text] [Related]
24. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
25. The prognostic role of pretreatment platelet-to-lymphocyte ratio as predictors in patients with colorectal cancer: a meta-analysis.
Min GT; Wang YH; Yao N; Zhao JM; Wang J; Wang HP; Chen W; Deng SJ; Li YM
Biomark Med; 2017 Jan; 11(1):87-97. PubMed ID: 27917650
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.
Cruz-Ramos M; Del Puerto-Nevado L; Zheng B; López-Bajo R; Cebrian A; Rodríguez-Remirez M; García-García L; Solanes-Casado S; García-Foncillas J
J Geriatr Oncol; 2019 Sep; 10(5):742-748. PubMed ID: 30327283
[TBL] [Abstract][Full Text] [Related]
27. Effects of Preoperative Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios on Survival in Patients with Extrahepatic Cholangiocarcinoma.
Kitano Y; Yamashita YI; Yamamura K; Arima K; Kaida T; Miyata T; Nakagawa S; Mima K; Imai K; Hashimoto D; Chikamoto A; Baba H
Anticancer Res; 2017 Jun; 37(6):3229-3237. PubMed ID: 28551669
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.
Leng J; Wu F; Zhang L
Front Oncol; 2022; 12():734948. PubMed ID: 35651788
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of PLR in various cancers: a meta-analysis.
Zhou X; Du Y; Huang Z; Xu J; Qiu T; Wang J; Wang T; Zhu W; Liu P
PLoS One; 2014; 9(6):e101119. PubMed ID: 24968121
[TBL] [Abstract][Full Text] [Related]
30. Platelet to lymphocyte ratio in biliary tract cancer: Review and meta-analysis.
Zhou LH; Luo XF
Clin Chim Acta; 2017 Nov; 474():102-107. PubMed ID: 28903023
[TBL] [Abstract][Full Text] [Related]
31. Systemic immune-inflammation index for predicting prognosis of colorectal cancer.
Chen JH; Zhai ET; Yuan YJ; Wu KM; Xu JB; Peng JJ; Chen CQ; He YL; Cai SR
World J Gastroenterol; 2017 Sep; 23(34):6261-6272. PubMed ID: 28974892
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of platelet to lymphocyte ratio in hepatocellular carcinoma: a systematic review and meta-analysis.
Zhao Y; Si G; Zhu F; Hui J; Cai S; Huang C; Cheng S; Fathy AH; Xiang Y; Li J
Oncotarget; 2017 Apr; 8(14):22854-22862. PubMed ID: 28206965
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.
Yodying H; Matsuda A; Miyashita M; Matsumoto S; Sakurazawa N; Yamada M; Uchida E
Ann Surg Oncol; 2016 Feb; 23(2):646-54. PubMed ID: 26416715
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer.
Wang J; Liu Y; Zhang N; Li X; Xin P; Bi J; Kong C
Oncotarget; 2017 Sep; 8(41):70874-70882. PubMed ID: 29050328
[TBL] [Abstract][Full Text] [Related]
35. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
36. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
[TBL] [Abstract][Full Text] [Related]
37. Prognostic evaluation of platelet to lymphocyte ratio in patients with colorectal cancer.
Lu C; Gao P; Yang Y; Chen X; Wang L; Yu D; Song Y; Xu Q; Wang Z
Oncotarget; 2017 Oct; 8(49):86287-86295. PubMed ID: 29156795
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological and prognostic significance of platelet-lymphocyte ratio (PLR) in gastric cancer: an updated meta-analysis.
Zhang X; Zhao W; Yu Y; Qi X; Song L; Zhang C; Li G; Yang L
World J Surg Oncol; 2020 Jul; 18(1):191. PubMed ID: 32731872
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological and prognostic significance of platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma.
Song W; Wang K; Zhong FP; Fan YW; Peng L; Zou SB
Oncotarget; 2016 Dec; 7(49):81830-81838. PubMed ID: 27833084
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Role of Platelet-to-Lymphocyte Ratio in Patients With Bladder Cancer: A Meta-Analysis.
Wang X; Ni X; Tang G
Front Oncol; 2019; 9():757. PubMed ID: 31475109
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
